Ahmed Shelbaya is a Senior Director of Outcomes & Evidence at Pfizer, and adjunct faculty at Columbia’s Mailman School of Public Health.
He trained as physician and practiced clinical pediatrics and neo-natal intensive care for nearly 14 years in developing country settings in the Middle East and Sub-Saharan Africa, before being involved in public health and public & global health policy. Before joining Mailman and Pfizer, Ahmed worked as a Senior Health Policy Analyst and Technical Coordinator for Health Sector Reform with several Ministers of Health in Egypt to support health policy generation and health sector reform. He was instrumental in the development of Egypt’s Basic Health Benefits Package of health services. That entailed calculating the burden of disease, as well as establishing a methodology for costing and cost effective analysis.
During his tenure he also designed and spearheaded the development of a health promotion, disease prevention national program “Healthy Egyptians 2010,” the National program was used in prioritizing limited resources towards cost-effective health interventions with greatest health impact. Ahmed’s public health activities also involved collaborating and working with the World Health Organization in Geneva on the Framework Convention for Tobacco Control, African Ministries of health as well as other international public health and multinational organizations in New York.
He has co-authored several publications related to anti-infectives, Malaria, HIV, Hepatitis C, CNS and Pain as well in the field of health policy. He holds a Medical degree, a Master of Science degree, and Master degree in Public Health.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).